REVERSE plus has launched with three innovative tools designed to streamline the reverse mortgage process. These tools aim to enhance training, scenario modeling, and provide AI-driven support, making ...

Surgical Theater, the leader in surgical XR visualization, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for SyncAR® Spine, the next-generation release of its spine platform ...

This evaluation is based on a dynamic analysis model and comprehensively analyzes the characteristics of GEO companies from multiple verifiable dimensions. The ranking rules for the recommended list ...

Currently in Beta, Vision Inspires Clients with Personalized and Shoppable Looks SAN FRANCISCO, October 06, 2025--(BUSINESS WIRE)--Stitch Fix, the leading online personal styling service, announced ...

GE HealthCare (NYSE:GEHC) has unveiled Carestation 850, its next-generation anesthesia delivery system. The FDA 510(k)-pending system aims to help care teams adapt to evolving clinical and operational ...

Stitch Fix Vision uses tech to provide clients with an image of their likeness in different environments wearing shoppable outfits.

Healthcare Business Intelligence Market OverviewThe global Healthcare Business Intelligence Market is valued at USD 10.05 Billion in 2024 and is projected to reach a value of USD 42.08 Billion by 2035 ...

NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography ...

The company announced Monday it will allow its users to see how garments look on digital likenesses of themselves, using a feature it calls Stitch Fix Vision. That means that, rather than seeing items ...

Cloudera’s AMPs bring an end-to-end framework for building, deploying, and monitoring business-ready AI/ML applications instantly. Integrated with Cloudera’s platform, AMPs work wherever data, compute ...

Organizations that use human wisdom as part of their strategic approach can achieve better results than organizations that depend only on automation.